Anne-Marie Mes-Masson has done pioneering work in the development of ovarian cancer model systems using human biological material. She has also helped establish standards concerning biospecimen banking, mainly with respect to its ethical aspects. In addition, she has made significant contributions to ovarian, prostate, breast and hereditary cancer research. Her leadership has been key to the success of many major oncology research programs. Her research has considerably enriched our understanding of the biology of ovarian cancer, and is being transferred to new clinical tools whose goal is to diagnose, manage and treat this fatal disease.

Pierrette Gaudreau devotes her research efforts to elucidating the central, peripheral, molecular and cellular mechanisms that help people age healthfully. She is also interested in biomarkers that predict health outcomes during aging. Her research is original in that it examines animal models of aging and cohorts of older adults with respect to neuroendocrine, metabolic and cognitive health, focusing mainly on the impact of diet as a determinant of successful aging.

The mission of the CAHS is to inform policy and practice by mobilizing the best scientific minds to provide independent evaluations based on evidence-based data related to health challenges affecting Canadians.